14 results on '"G. Hoarau"'
Search Results
2. A population in perpetual motion: Highly dynamic roosting behavior of a tropical island endemic bat
- Author
-
Samantha Aguillon, Gildas Le Minter, Camille Lebarbenchon, Axel O. G. Hoarau, Céline Toty, Léa Joffrin, Riana V. Ramanantsalama, Stéphane Augros, Pablo Tortosa, Patrick Mavingui, and Muriel Dietrich
- Subjects
Ecology ,Ecology, Evolution, Behavior and Systematics ,Nature and Landscape Conservation - Published
- 2023
- Full Text
- View/download PDF
3. Synchronicity of viral shedding in molossid bat maternity colonies
- Author
-
Axel O. G. Hoarau, Marie Köster, Muriel Dietrich, Gildas Le Minter, Léa Joffrin, Riana V. Ramanantsalama, Patrick Mavingui, and Camille Lebarbenchon
- Subjects
Infectious Diseases ,Epidemiology - Abstract
Infection dynamics in vertebrates are driven by biological and ecological processes. For bats, population structure and reproductive cycles have major effects on RNA virus transmission. On Reunion Island, previous studies have shown that parturition of pregnant females and aggregation of juvenile Reunion free-tailed bats (Mormopterus francoismoutoui) are associated with major increase in the prevalence of bats shedding RNA viruses. The synchronicity of such shedding pulses, however, is yet to be assessed between viruses but also maternity colonies. Based on 3422 fresh faeces collected every 2–5 weeks during four consecutive birthing seasons, we report the prevalence of bats shedding astroviruses (AstVs), coronaviruses (CoVs) and paramyxoviruses (PMVs) in two maternity colonies on Reunion Island. We found that the proportion of bats shedding viruses is highly influenced by sampling collection periods, and therefore by the evolution of the population age structure. We highlight that virus shedding patterns are consistent among years and colonies for CoVs and to a lesser extent for PMVs, but not for AstVs. We also report that 1% of bats harbour co-infections, with two but not three of the viruses, and most co-infections were due to CoVs and PMVs.
- Published
- 2023
- Full Text
- View/download PDF
4. Genome-wide phylogeography reveals cryptic speciation in the circumglobal planktonic calcifier Limacina bulimoides
- Author
-
L. Q. Choo, G. Spagliardi, M. Malinsky, M. Choquet, E. Goetze, G. Hoarau, and K. T. C. A. Peijnenburg
- Subjects
Genetics ,570 Life sciences ,biology ,Ecology, Evolution, Behavior and Systematics - Abstract
Little is known about when and how planktonic species arise and persist in the open ocean without apparent dispersal barriers. Pteropods are planktonic snails with thin shells susceptible to dissolution that are used as bio-indicators of ocean acidification. However, distinct evolutionary units respond to acidification differently and defining species boundaries is therefore crucial for predicting the impact of changing ocean conditions. In this global population genomic study of the shelled pteropod Limacina bulimoides, we combined genetic (759,000 single nucleotide polymorphisms) and morphometric data from 161 individuals, revealing three major genetic lineages (FST = 0.29 to 0.41): an 'Atlantic lineage' sampled across the Atlantic, an 'Indo-Pacific lineage' sampled in the North Pacific and Indian Ocean, and a 'Pacific lineage' sampled in the North and South Pacific. A time-calibrated phylogeny suggests that the lineages diverged about one million years ago, with estimated effective population size remaining high (~10 million) throughout Pleistocene glacial cycles. We do not observe any signatures of recent hybridisation, even in areas of sympatry in the North Pacific. While the lineages are reproductively isolated, they are morphologically cryptic, with overlapping shell shape and shell colour distributions. Despite showing that the circumglobal L. bulimoides consists of multiple species with smaller ranges than initially thought, we found that these pteropods still possess high levels of genetic variability. Our study adds to the growing evidence that speciation is often overlooked in the open ocean, and suggests the presence of distinct biological species within many other currently defined circumglobal planktonic species.
- Published
- 2023
- Full Text
- View/download PDF
5. CHAPTER 6 ZOONOTIC PATHOGENS AND OTHER INFECTIOUS MICROBES: DIVERSITY, EVOLUTIONARY HISTORY, AND TRANSMISSION
- Author
-
P. Tortosa, M. Dietrich, Y. Gomard, C. Cordonin, A. O. G. Hoarau, S. F. Andriamandimby, L. Joffrin, C. E. Brook, H. A. Rabemananjara, C. Filippone, D. Wilkinson, J.-M. Héraud, C. Lebarbenchon, M.-M. Olive, H. Guis, V. Miatrana Rasamoelina, L. Tantely, P. Mavingui, B. Ramasindrazana, M. Rasoanoro, H. C. Ranaivoson, M. Randrianarivelojosia, S. M. Goodman, F. Rasambainarivo, and S. Zohdy
- Published
- 2022
- Full Text
- View/download PDF
6. Microsporidial keratoconjunctivitis: Report of two imported cases
- Author
-
Nacim Bouheraoua, Françoise Brignole-Baudouin, G. Hoarau, Cristina Georgeon, Lilia Merabet, J. Knoeri, P. Poirier, and Vincent Borderie
- Subjects
Ophthalmology ,medicine.medical_specialty ,business.industry ,Keratoconjunctivitis ,Medicine ,Humans ,business ,medicine.disease ,Dermatology ,Eye Infections, Fungal - Published
- 2020
7. Mucormycose hépatique à Rhizopus microsporus : description d’un cas
- Author
-
Nathalie Coolen-Allou, Jérôme Allyn, M. Lagrange-Xelot, C. Fernandez, Nicolas Allou, G. Le Gac, and G. Hoarau
- Subjects
0301 basic medicine ,Rhizopus microsporus ,biology ,business.industry ,030106 microbiology ,Mucormycosis ,biology.organism_classification ,medicine.disease ,Microbiology ,03 medical and health sciences ,Infectious Diseases ,Rhizopus ,medicine ,business - Published
- 2017
- Full Text
- View/download PDF
8. QUALIFICATION D'UN DISPOSITIF EXPÉRIMENTAL PERMETTANT L'ÉTUDE D'UN MONITEUR DE LA CONTAMINATION ATMOSPHÉRIQUE DANS DES CONDITIONS REPRÉSENTATIVES DE CHANTIERS DE DÉMANTÈLEMENT
- Author
-
G. HOARAU, G. DOUGNIAUX, F. GENSDARMES, B. DHIEUX LESTAEVEL, J. LAURENT, and P. CASSETTE
- Subjects
granulométrie d'aérosol ,particle size distribution ,homogeneity of the aerosol mass concentration ,homogénéité en concentration - Abstract
Cet article présente un nouveau dispositif dans lequel est simulée une atmosphère représentative des conditions de chantiers de démantèlement. Ce dispositif est utilisé pour l'étude de la réponse d'un moniteur de mesure de la contamination atmosphérique dans de telles conditions. Dans cet article, nous présentons le dispositif expérimental et la caractérisation de l'exposition d'un moniteur de la contamination atmosphérique pour un aérosol type.
- Published
- 2019
- Full Text
- View/download PDF
9. HTLV-1 infection in Reunion
- Author
-
H. Renard, G. Hoarau, P. Aubry, and Bernard-Alex Gaüzère
- Subjects
Male ,0301 basic medicine ,viruses ,030106 microbiology ,Biology ,Asymptomatic ,03 medical and health sciences ,HTLV Infections ,immune system diseases ,Administrative database ,hemic and lymphatic diseases ,Tropical spastic paraparesis ,medicine ,Humans ,Aged ,virus diseases ,Middle Aged ,medicine.disease ,University hospital ,HTLV-I Infections ,Virology ,Lymphoma ,Leukemia ,Infectious Diseases ,Immunology ,Female ,HTLV-1 Infection ,medicine.symptom ,Reunion - Abstract
Objectives Although regularly looked for in blood donors, HTLV infections are very rare in Reunion. We aimed to describe HTLV infections locally. Patients and methods HTLV infections were identified from the database of the Reunion University Hospital administrative database (PMSI) between 2000 and 2016. Diagnosis was performed with HTLV 1/2 enzyme immunoassay test and confirmed by Western blot. Results We reported three asymptomatic and four symptomatic HTLV infections, including two tropical spastic paraparesis/HTLV-1 associated myelopathies (TSP/HAM) and two adult T-cell leukemia/lymphoma (ATLL), diagnosed between 2000 and 2016. Conclusion Reunion is a low HTLV prevalence area, which could be explained by its settlement history. The present report underlines the local circulation of HTLV and symptomatic infections.
- Published
- 2017
- Full Text
- View/download PDF
10. Candidemia in the intensive care unit: A 12-year retrospective cohort study in Reunion Island
- Author
-
J. Peytral, P. Poubeau, Patrick Gérardin, E. Antok, G. Hoarau, X. Coueffe, C. Mohr, J. Lemant, P. Zunic, and S. Picot
- Subjects
0301 basic medicine ,Antifungal ,Male ,medicine.medical_specialty ,Time Factors ,medicine.drug_class ,030106 microbiology ,Candida parapsilosis ,law.invention ,Candida tropicalis ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,law ,Internal medicine ,Epidemiology ,medicine ,Humans ,030212 general & internal medicine ,Candida albicans ,Retrospective Studies ,biology ,Candida glabrata ,business.industry ,Incidence ,Candidemia ,Retrospective cohort study ,Middle Aged ,biology.organism_classification ,Intensive care unit ,Intensive Care Units ,Infectious Diseases ,Female ,business ,Reunion - Abstract
Objectives We aimed to describe the epidemiology of Candida bloodstream infection in an intensive care unit (ICU) in Reunion Island. Methods We performed a retrospective cohort study and evaluated 63 candidemia episodes, which occurred between January 2004 and December 2015 in the ICU of a University Hospital in St-Pierre. Results The incidence rate of candidemia in the ICU was estimated at 7.6%. Candida albicans was the most common yeast pathogen species recovered (54%), followed by Candida glabrata (17%), Candida tropicalis (12%) and Candida parapsilosis (10%). Between 2012 and 2015, we also observed a modification of antifungal use. Conclusion The epidemiology of candidemia in Reunion Island is characterized by the predominance of Candida albicans and by the relative importance of Candida tropicalis. This pattern corresponds to a model of epidemiological transition between the one usually observed in tropical areas and the one observed in temperate countries.
- Published
- 2017
11. In vitro and in vivo evaluation of fluoroquinolone resistance associated with DNA gyrase mutations in Francisella tularensis, including in tularaemia patients with treatment failure
- Author
-
V. Sutera, Patricia Renesto, Yvan Caspar, G. Hoarau, Max Maurin, Service de bactériologie, parasitologie, virologie et hygiène hospitalière [La réunion], Groupe Hospitalier Sud-CHR La réunion, Thérapeutique Recombinante Expérimentale (TIMC-IMAG-TheREx), Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications, Grenoble - UMR 5525 (TIMC-IMAG), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Laboratoire Adaptation et pathogénie des micro-organismes [Grenoble] (LAPM), and Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)
- Subjects
0301 basic medicine ,Microbiology (medical) ,Adult ,Male ,medicine.drug_class ,030106 microbiology ,Antibiotics ,Drug resistance ,Microbial Sensitivity Tests ,medicine.disease_cause ,DNA gyrase ,Polymerase Chain Reaction ,Microbiology ,03 medical and health sciences ,Minimum inhibitory concentration ,Antibiotic resistance ,Drug Resistance, Bacterial ,medicine ,Humans ,Pharmacology (medical) ,Treatment Failure ,Francisella tularensis ,Tularemia ,ComputingMilieux_MISCELLANEOUS ,Aged ,Aged, 80 and over ,Mutation ,Antiinfective agent ,biology ,[SDV.BBM.BS]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Structural Biology [q-bio.BM] ,General Medicine ,Middle Aged ,biology.organism_classification ,Virology ,[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology ,3. Good health ,Anti-Bacterial Agents ,Infectious Diseases ,DNA Gyrase ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Female ,Fluoroquinolones - Abstract
Fluoroquinolones (FQs) are highly effective for treating tularaemia, a zoonosis caused by Francisella tularensis , but failures and relapses remain common in patients with treatment delay or immunocompromised status. FQ-resistant strains of F. tularensis harboring mutations in the quinolone–resistance determining region (QRDR) of gyrA and gyrB, the genes encoding subunits A and B of DNA gyrase, have been selected in vitro. Such mutants have never been isolated from humans as this microorganism is difficult to culture. In this study, the presence of FQ-resistant mutants of F. tularensis was assessed in tularaemia patients using combined culture- and PCR-based approaches. We analyzed 42 F. tularensis strains and 82 tissue samples collected from 104 tularaemia cases, including 32 (30.7%) with FQ treatment failure or relapse. Forty F. tularensis strains and 55 clinical samples were obtained before any FQ treatment, while 2 strains and 15 tissue samples were collected after treatment. FQ resistance was evaluated by the minimum inhibitory concentration (MIC) for the bacterial strains, and by newly developed PCR-based methods targeting the gyrA and g yrB QRDRs for both the bacterial strains and the clinical samples. None of the F. tularensis strains displayed an increased MIC compared with FQ–susceptible controls. Neither gyrA nor gyrB QRDR mutation was found in bacterial strains and tissue samples tested, including those from patients with FQ treatment failure or relapse. Further phenotypic and genetic resistance traits should be explored to explain the poor clinical response to FQ treatment in such tularaemia patients.
- Published
- 2016
- Full Text
- View/download PDF
12. Geographically specific heteroplasmy of mitochondrial DNA in the seaweed, Fucus serratus (Heterokontophyta: Phaeophyceae, Fucales)
- Author
-
J A, Coyer, G, Hoarau, W T, Stam, and J L, Olsen
- Subjects
Europe ,Genetics, Population ,Base Sequence ,Geography ,Haplotypes ,Fucus ,Molecular Sequence Data ,Genetic Variation ,Sequence Analysis, DNA ,DNA, Mitochondrial ,Sequence Alignment ,Polymorphism, Single-Stranded Conformational - Abstract
The presence of more than one type of mitochondrial DNA within the same organism (mtDNA heteroplasmy) has been reported in vertebrates, invertebrates, basidiomycetes and some angiosperms, but never in marine (macro)algae. We examined sequence differences in a 135-base pair (bp) region of the nad11 gene in mitochondria of the intertidal rockweed, Fucus serratus, using single-strand conformation polymorphism (SSCP). Each of 70 and 22 individuals from Blushøj (Denmark) and Oskarshamn (Sweden), respectively, displayed haplotypes 2, 3, and 4 (= mtDNA heteroplasmy), whereas only haplotype 2 was found in each of 24 individuals from locations in Spain, France, Ireland, Iceland and Norway. As Blushøj and Oskarshamn were among the last areas to emerge from ice cover during the Last Glacial Maximum (18000-20000 years BP), the geographically specific heteroplasmy may represent a founder effect and therefore, a valuable marker for understanding the role of post-Ice Age recolonization. Geographically specific heteroplasmy also has important implications in phylogeographical studies based on mtDNA sequences.
- Published
- 2004
13. Epidémiologie
- Author
-
G. Hoarau
- Subjects
Infectious Diseases - Published
- 2014
- Full Text
- View/download PDF
14. Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations
- Author
-
Desnos-Ollivier, Marie, Bretagne, Stéphane, Lortholary, Olivier, Dromer, Françoise, French Mycoses Study Group, The, Mycologie moléculaire - Molecular Mycology, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence Mycoses Invasives et Antifongiques - National Reference Center Invasive Mycoses & Antifungals (CNRMA), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Laboratoire de Parasitologie-Mycologie [CHU Saint Louis, Paris], Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre d'infectiologie Necker-Pasteur [CHU Necker], Institut Pasteur [Paris] (IP)-CHU Necker - Enfants Malades [AP-HP], Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), This work was supported by Santé Publique France and Institut Pasteur., Members of the French Mycoses Study Group who contributed to the data are, in alphabetical order of the cities, all the French microbiologists and mycologists who sent isolates for characterization of unusual antifungal susceptibility profiles or to contribute to the ongoing surveillance program on the epidemiology of invasive fungal infections in France (YEASTS and RESSIF programs): N. Brieu (CH Aix), T. Chouaki, C. Damiani, A. Totet (CHU Amiens), J. P. Bouchara, D. Chabasse, M. Pihet (CHU Angers), S. Bland (CH Annecy), V. Blanc (CH Antibes), S. Branger (CH Avignon), A. P. Bellanger, L. Millon (CHU Besançon), C. Plassart (CH Beauvais), I. Poilane (Hôpital Jean Verdier, Bondy), I. Accoceberry, L. Delhaes, B. Couprie, F. Gabriel (CH Bordeaux), J. Dunand, A. L. Roux, V. Sivadon-Tardy (Hôpital Ambroise Paré, Boulogne Billancourt), F. Laurent (CH, Bourg en Bresse), S. Legal, E. Moalic, G. Nevez, D. Quinio (CHU Brest), M. Cariou (CH Bretagne Sud), J. Bonhomme, C. Duhamel (CHU, Caen), B. Podac (CH, Chalon sur Saône), S. Lechatch (CH, Charleville-Mézières), C. Soler (Hopital d’Instruction des armées, Clamart), M. Cambon, C. Nourrisson, P. Poirier, D. Pons (CHU, Clermont Ferrand), O. Augereau, I. Grawey (CH, Colmar), N. Fauchet (CHIC, Créteil), A. Bonnin, F. Dalle (CHU, Dijon), P. Cahen, P. Honderlick (CMC, Foch), N. Desbois, C. Miossec (CHU, Fort de France), J. L. Hermann (Hôpital Raymond Poincaré, Garches), M. Cornet, R. Grillot, B. Lebeau, D. Maubon, H. Pelloux (CHU, Grenoble), M. Nicolas (CHU, Guadeloupe), C. Aznar, D. Blanchet, J. F. Carod, M. Demar, (CHU, Guyane), A. Angoulvant (Hôpital Bicêtre, le Kremlin Bicêtre), C. Ciupek (CH, Le Mans), A. Gigandon (Hôpital Marie Lannelongue, Le Plessis Robinson), B. Bouteille (CH Limoges), E. Frealle, D. Poulain, B. Sendid (CHU Lille), D. Dupont, J. Menotti, F. Persat, M.-A. Piens, M. Wallon (CHU, Lyon), C. Cassagne, S. Ranque (CHU, Marseille), T. Benoit-Cattin, L. Collet (CH Mayotte), A. Fiacre (CH Meaux), N. Bourgeois, L. Lachaud, P. Rispail, Y. Sterkers (CHU, Montpellier), M. Machouart (CHU, Nancy), F. Gay-Andrieu, P. Lepape, F. Morio (CHU, Nantes), O. Moquet (CH, Nevers), S. Lefrançois (Hôpital Américain, Neuilly), M. Sasso (CHU, Nimes), F. Reibel (GH, Nord-Essone), M. Gari-Toussaint, L. Hasseine (CHU Nice), L. Bret, D. Poisson (CHR Orléans), S. Brun (Hôpital Avicenne, Paris), C. Bonnal, C. Chochillon, S. Houzé (Hôpital Bichat, Paris), A. Paugam (Hôpital Cochin, Paris), N. Ait-Ammar, F. Botterel, R. Chouk (CHU Henri Mondor, Paris), M. E. Bougnoux, E. Sitterle (Hôpital Necker, Paris), A. Fekkar, R. Piarroux (Hôpital Pitié Salpêtrière, Paris), J. Guitard, C. Hennequin, J.-L. Poirot (Hôpital St Antoine, Paris), M. Gits-Muselli, S. Hamane, C. Lacroix (Hôpital Saint Louis, Paris), S. Bonacorsi, P. Mariani (Hôpital Robert Debré, Paris), D. Moissenet (Hôpital Trousseau, Paris), C. Kauffmann-Lacroix, A. Minoza, E. Perraud, M. H. Rodier (CHU Poitiers), G. Colonna (CH, Porto Vecchio), A. Huguenin, D. Toubas (CHU Reims), S. Chevrier, J. P. Gangneux, F. Robert-Gangneux, C. Guigen (CHU Rennes), O. Belmonte, G. Hoarau, M. C. Jaffar Bandjee, J. Jaubert, S. Picot, N. Traversier (CHU Réunion), L. Favennec, G. Gargala (CHU, Rouen), N. Godineau, C. Tournus (CH, St Denis), C. Mahinc, H. Raberin (CHU, St Etienne), V. Letscher Bru (CHU, Strasbourg), S. Cassaing (CHU, Toulouse), P. Patoz (CH Tourcoing), E. Bailly, J. Chandenier, G. Desoubeaux (CHU Tours), F. Moreau (CH Troyes), P. Munier (CH Valence), E. Mazars (CH Valenciennes), O. Eloy (CH Versailles), E. Chachaty (Institut Gustave Roussy, Villejuif), and and members of the NRCMA (Institut Pasteur, Paris): A. Bertho, C. Blanc, A. Boullié, C. Gautier, V. Geolier, D. Hoinard, and D. Raoux-Barbot for technical help, and K. Boukris-Sitbon, F. Lanternier, A. Alanio, and D. Garcia-Hermoso for their expertise and contribution to the surveillance programs.
- Subjects
Pharmacology ,Antifungal Agents ,[SDV]Life Sciences [q-bio] ,yeasts ,Microbial Sensitivity Tests ,antifungal resistance ,Anidulafungin ,bacterial infections and mycoses ,rare yeast ,common yeast ,Echinocandins ,Lipopeptides ,Infectious Diseases ,Susceptibility ,Caspofungin ,Drug Resistance, Fungal ,Mutation ,Micafungin ,polycyclic compounds ,FKS mutation ,Humans ,Candidiasis, Invasive ,Pharmacology (medical) ,MIC distribution - Abstract
International audience; Since echinocandins are recommended as first line therapy for invasive candidiasis, detection of resistance, mainly due to alteration in FKS protein, is of main interest. EUCAST AFST recommends testing both MIC of anidulafungin and micafungin, and breakpoints (BPs) have been proposed to detect echinocandin-resistant isolates. We analyzed MIC distribution for all three available echinocandins of 2,787 clinical yeast isolates corresponding to 5 common and 16 rare yeast species, using the standardized EUCAST method for anidulafungin and modified for caspofungin and micafungin (AM3-MIC). In our database, 64 isolates of common pathogenic species were resistant to anidulafungin, according to the EUCAST BP, and/or to caspofungin, using our previously published threshold (AM3-MIC ≥ 0.5 mg/L). Among these 64 isolates, 50 exhibited 21 different FKS mutations. We analyzed the capacity of caspofungin AM3-MIC and anidulafungin MIC determination in detecting isolates with FKS mutation. They were always identified using caspofungin AM3-MIC and the local threshold while some isolates were misclassified using anidulafungin MIC and EUCAST threshold. However, both methods misclassified four wild-type C. glabrata as resistant. Based on a large data set from a single center, the use of AM3-MIC testing for caspofungin looks promising in identifying non-wild-type C. albicans, C. tropicalis and P. kudiravzevii isolates, but additional multicenter comparison is mandatory to conclude on the possible superiority of AM3-MIC testing compared to the EUCAST method.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.